메뉴 건너뛰기
Psychiatry Investigation
Volumn 12, Issue 3, 2015, Pages 417-419
Why systematic review rather than narrative review?
Author keywords

[No Author keywords available]
Indexed keywords

COMORBIDITY; DATA EXTRACTION; DISEASE SEVERITY; HUMAN; LETTER; LITERATURE; PEER REVIEW; POSTTRAUMATIC STRESS DISORDER;
EID: 84937841425     PISSN: 17383684     EISSN: 19763026     Source Type: Journal    
DOI: 10.4306/pi.2015.12.3.417     Document Type: Letter
Times cited : (139)
References (12)
  • 1
    • 84937878656 scopus 로고    scopus 로고
    • What is a systematic review?
    • April 2009, Accessed July 3, 2014
    • Huw TO, Crombie DI. What is a systematic review? Evidence-based medicine. April 2009. Available on http://www.medicine.ox.ac.uk. Accessed July 3, 2014.
    • Evidence-Based Medicine
    • Huw, T.O.1    Crombie, D.I.2
  • 2
    • 0142137105 scopus 로고    scopus 로고
    • Comparison of systematic and narrative reviews: The example of the atypical antipsychotics
    • Cipriani A, Geddes J. Comparison of systematic and narrative reviews: the example of the atypical antipsychotics. Epidemiol Psichiatr Soc 2003;12:146-153.
    • (2003) Epidemiol Psichiatr Soc , vol.12 , pp. 146-153
    • Cipriani, A.1    Geddes, J.2
  • 3
    • 84903779829 scopus 로고    scopus 로고
    • The po-tential role of atypical antipsychotics for the treatment of posttraumatic stress disorder
    • Han C, Pae CU, Wang SM, Lee SJ, Patkar AA, Masand PS, et al. The po-tential role of atypical antipsychotics for the treatment of posttraumatic stress disorder. J Psychiatr Res 2014;56:72-81.
    • (2014) J Psychiatr Res , vol.56 , pp. 72-81
    • Han, C.1    Pae, C.U.2    Wang, S.M.3    Lee, S.J.4    Patkar, A.A.5    Masand, P.S.6
  • 4
    • 84886301183 scopus 로고    scopus 로고
    • Clinical issues in use of atypical antipsychotics for depressed patients
    • Pae CU, Patkar AA. Clinical issues in use of atypical antipsychotics for depressed patients. CNS Drugs 2013;27(Suppl 1):S39-S45.
    • (2013) CNS Drugs , vol.27 , Issue.1 , pp. S39-S45
    • Pae, C.U.1    Patkar, A.A.2
  • 5
    • 84888133833 scopus 로고    scopus 로고
    • Atypical antipsychotics in the treatment of posttraumatic stress disorder
    • Wang HR, Woo YS, Bahk WM. Atypical antipsychotics in the treatment of posttraumatic stress disorder. Clin Neuropharmacol 2013;36:216-222.
    • (2013) Clin Neuropharmacol , vol.36 , pp. 216-222
    • Wang, H.R.1    Woo, Y.S.2    Bahk, W.M.3
  • 6
    • 84892925800 scopus 로고    scopus 로고
    • Burning issues in the metaanalysis of pharmaceutical trials for depression
    • Fountoulakis KN, Samara MT, Siamouli M. Burning issues in the metaanalysis of pharmaceutical trials for depression. J Psychopharmacol 2014;28:106-117.
    • (2014) J Psychopharmacol , vol.28 , pp. 106-117
    • Fountoulakis, K.N.1    Samara, M.T.2    Siamouli, M.3
  • 7
    • 5444225306 scopus 로고    scopus 로고
    • Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related posttraumatic stress disorder
    • Pivac N, Kozaric-Kovacic D, Muck-Seler D. Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related posttraumatic stress disorder. Psychopharmacology (Berl) 2004;175:451-456.
    • (2004) Psychopharmacology (Berl) , vol.175 , pp. 451-456
    • Pivac, N.1    Kozaric-Kovacic, D.2    Muck-Seler, D.3
  • 8
    • 84859120551 scopus 로고    scopus 로고
    • How informative are open-label studies for youth with bipolar disorder? A meta-analysis comparing open-label versus randomized, placebo-controlled clinical trials
    • Biederman J, Petty CR, Woodworth KY, Lomedico A, O’Connor KB, Wozniak J, et al. How informative are open-label studies for youth with bipolar disorder? A meta-analysis comparing open-label versus randomized, placebo-controlled clinical trials. J Clin Psychiatry 2012;73: 358-365.
    • (2012) J Clin Psychiatry , vol.73 , pp. 358-365
    • Biederman, J.1    Petty, C.R.2    Woodworth, K.Y.3    Lomedico, A.4    O’connor, K.B.5    Wozniak, J.6
  • 9
    • 84928160578 scopus 로고    scopus 로고
    • A meta-analysis comparing open-label versus placebo-controlled clinical trials for aripiprazole augmentation in the treatment of major depressive disorder: Lessons and Promises
    • Pae CU, Seo HJ, Lee BC, Seok JH, Jeon HJ, Paik JW, et al. A meta-analysis comparing open-label versus placebo-controlled clinical trials for aripiprazole augmentation in the treatment of major depressive disorder: Lessons and Promises. Psychiatry Investig 2014;11:371-379.
    • (2014) Psychiatry Investig , vol.11 , pp. 371-379
    • Pae, C.U.1    Seo, H.J.2    Lee, B.C.3    Seok, J.H.4    Jeon, H.J.5    Paik, J.W.6
  • 11
    • 80051796810 scopus 로고    scopus 로고
    • Novel melatonin-based therapies: Potential advances in the treatment of major depression
    • Hickie IB, Rogers NL. Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet 2011;378:621-631.
    • (2011) Lancet , vol.378 , pp. 621-631
    • Hickie, I.B.1    Rogers, N.L.2
  • 12
    • 84893662317 scopus 로고    scopus 로고
    • Agomelatine: A new option for treatment of depression?
    • Pae CU. Agomelatine: a new option for treatment of depression? Expert Opin Pharmacother 2014;15:443-447.
    • (2014) Expert Opin Pharmacother , vol.15 , pp. 443-447
    • Pae, C.U.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.